Therapeutic Fasting and Immune Aging (NCT05857241) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
Therapeutic Fasting and Immune Aging
France20 participantsStarted 2025-04
Plain-language summary
Immunosenescence is the age-related decline of the immune system, involving a state of chronic inflammation and a decrease in the diversity/adaptability of the lymphocyte repertoire. The consequences of immunosenescence are multiple, including increased susceptibility to infections and poorer vaccine responses.
Who can participate
Age range65 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria :
* Patient affiliated or entitled to a social security scheme
* Residing in a Long-Term Care Unit (LTCU) or a Facility for the Elderly Dependent (EHPAD)
* A person deemed a priori, by the geriatrician member of the monitoring committee, to be capable of following the dietary recommendations required for the study.
* A person deemed a priori, by the clinician in charge, to be able to follow the dietary recommendations required by the study.
* Patient who has received informed information about the study and has co-signed a consent to participate in the study with the investigator.
Exclusion Criteria :
* Inability and/or unwillingness to follow dietary recommendations and/or perform follow-up examinations required for the study
* Iso-resource group 1 or 2 according to the AGGIR grid
* BMI \< 18.5 kg/m2 or recent weight loss \> 5% in 1 month or recent weight loss \> 10% in 6 months from previous weight
* Albuminemia \< 30g/l
* All swallowing disorders requiring a specific diet.
* Influenza vaccination received prior to inclusion
* Episode of influenza or suspected influenza during the 2020-2021 season and prior to inclusion
* Any acute medical or surgical event less than 2 weeks prior to inclusion
* Presence of systemic inflammatory or autoimmune disease
* Presence of an innate or acquired immune deficiency (including taking immunosuppressive treatment)
* Presence of a chronic disease which, according to the physician, makes the follow-up of a "fasting die…
What they're measuring
1
rate of premature discontinuation of the fasting-mimicking diet
Timeframe: between Day 14 and Day 21
Trial details
NCT IDNCT05857241
SponsorCentre Hospitalier Universitaire de Saint Etienne